Future technology insight: Mass spectrometry imaging as a tool in drug research and development

British Journal of Pharmacology

Volumn 172, Issue 13, 2015, Pages 3266-3283

  Cobice, D F ^a   Goodwin, R J A ^b   Andren, P E ^c   Nilsson, A ^c   Mackay, C L ^d   Andrew, R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ASTRAZENECA   (United Kingdom)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; IMATINIB; OXALIPLATIN; PACLITAXEL; TIOTROPIUM BROMIDE;

DATA PROCESSING; DERIVATIZATION; DRUG APPROVAL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG RESEARCH; DRUG SCREENING; HUMAN; IN VIVO STUDY; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; TISSUE SECTION; TOXICOLOGY; WHOLE BODY AUTORADIOGRAPHY; ANIMAL; DEVICES; DIAGNOSTIC IMAGING; DRUG DEVELOPMENT; PROCEDURES; RESEARCH;

ANIMALS; DIAGNOSTIC IMAGING; DRUG DISCOVERY; HUMANS; MASS SPECTROMETRY; RESEARCH;

EID: 84937500797     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13135     Document Type: Review

References (129)

1. Aboagye EO, Bhujwalla ZM, (1999). Malignant transformation alters membrane choline phospholipid metabolism of human mammary epithelial cells. Cancer Res 59: 80-84.
2. Ackerstaff E, Gimi B, Artemov D, Bhujwalla ZM, (2007). Anti-inflammatory agent indomethacin reduces invasion and alters metabolism in a human breast cancer cell line. Neoplasia 9: 222-235.
3. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol, 170: 1797-1867.
4. Altelaar AF, van Minnen J, Jimenez CR, Heeren RM, Piersma SR, (2005). Direct molecular imaging of Lymnaea stagnalis nervous tissue at subcellular spatial resolution by mass spectrometry. Anal Chem 77: 735-741.
5. Altelaar AF, Luxembourg SL, McDonnell LA, Piersma SR, Heeren RM, (2007). Imaging mass spectrometry at cellular length scales. Nat Protoc 2: 1185-1196.
6. Amstalden van Hove ER, Smith DF, Heeren RM, (2010). A concise review of mass spectrometry imaging. J Chromatogr A 1217: 3946-3954.
7. Anderson DM, Mills D, Spraggins J, Lambert WS, Calkins DJ, Schey KL, (2013). High-resolution matrix-assisted laser desorption ionization-imaging mass spectrometry of lipids in rodent optic nerve tissue. Mol Vis 19: 581-592.
8. Artemov D, Bhujwalla ZM, Maxwell RJ, Griffiths JR, Judson IR, Leach MO, et al. (1995). Pharmacokinetics of the 13C labeled anticancer agent temozolomide detected in vivo by selective cross-polarization transfer. Magn Reson Med 34: 338-342.
9. Atkinson SJ, Loadman PM, Sutton C, Patterson LH, Clench MR, (2007). Examination of the distribution of the bioreductive drug AQ4N and its active metabolite AQ4 in solid tumours by imaging matrix-assisted laser desorption/ionisation mass spectrometry. Rapid Commun Mass Spectrom 21: 1271-1276.
10. Ayorinde FO, Hambright P, Porter TN, Keith QL Jr, (1999). Use of meso-tetrakis (pentafluorophenyl) porphyrin as a matrix for low molecular weight alkylphenol ethoxylates in laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 13: 2474-2479.
11. Benninghoven A, Sichtermann WK, (1978). Detection, identification and structural investigation of biologically important compounds by secondary ion mass spectrometry. Anal Chem 50: 1180-1184.
12. Bouslimani A, Bec N, Glueckmann M, Hirtz C, Larroque C, (2010). Matrix-assisted laser desorption/ionization imaging mass spectrometry of oxaliplatin derivatives in heated intraoperative chemotherapy (HIPEC)-like treated rat kidney. Rapid Commun Mass Spectrom 24: 415-421.
13. Boutaud O, Montine TJ, Chang L, Klein WL, Oates JA, (2006). PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42. J Neurochem 96: 917-923.
14. Caprioli R, (2007). MALDI mass spectrometry for direct tissue analysis: a new tool for biomarker discovery. J Proteome Res 4: 1138-1142.
15. Caprioli RM, Farmer TB, Gile J, (1997). Molecular imaging of biological samples: localization of peptides and proteins using MALDI-ToF MS. Anal Chem 69: 4751-4760.
16. Casadonte R, Caprioli RM, (2011). Proteomic analysis of formalin-fixed paraffin-embedded tissue by MALDI imaging mass spectrometry. Nat Protoc 6: 1695-1709.
17. Castellino S, Groseclose MR, Wagner D, (2011). MALDI imaging mass spectrometry: bridging biology and chemistry in drug development. Bioanalysis 3: 2427-2441.
18. Chacon A, Zagol-Ikapitte I, Amarnath V, Reyzer ML, Oates JA, Caprioli RM, et al. (2011). On-tissue chemical derivatization of 3-methoxysalicylamine for MALDI-imaging mass spectrometry. J Mass Spectrom 46: 840-846.
19. Chaurand P, DaGue BB, Pearsall RS, Threadgill DW, Caprioli RM, (2001). Profiling proteins from azoxymethane-induced colon tumors at the molecular level by matrix-assisted laser desorption/ionization mass spectrometry. Proteomics 1: 1320-1326.
20. Chaurand P, Schwartz SA, Billheimer D, Xu BJ, Crecelius A, Caprioli RM, (2004). Integrating histology and imaging mass spectrometry. Anal Chem 76: 1145-1155.
21. Chen CT, Chen YC, (2004). Molecularly imprinted TiO2-matrix-assisted laser desorption/ionization mass spectrometry for selectively detecting alpha-cyclodextrin. Anal Chem 76: 1453-1457.
22. Chen Y, Allegood J, Liu Y, Wang E, Cachon-Gonzalez B, Cox TM, et al. (2008). Imaging MALDI mass spectrometry using an oscillating capillary nebulizer matrix coating system and its application to analysis of lipids in brain from a mouse model of Tay-Sachs/Sandhoff disease. Anal Chem 80: 2780-2788.
23. Chughtai K, Heeren RM, (2010). Mass spectrometric imaging for biomedical tissue analysis. Chem Rev 110: 3237-3277.
24. Cobice DF, Mackay CL, Goodwin RJ, McBride A, Langridge-Smith PR, Webster SP, et al. (2013). Mass spectrometry imaging for dissecting steroid intracrinology within target tissues. Anal Chem 85: 11576-11584.
25. Cornett DS, Frappier SL, Caprioli RM, (2008). MALDI-FTICR imaging mass spectrometry of drugs and metabolites in tissue. Anal Chem 80: 5648-5653.
26. Crank JA, Armstrong DW, (2009). Towards a second generation of ionic liquid matrices (ILMs) for MALDI-MS of peptides, proteins, and carbohydrates. J Am Soc Mass Spectrom 20: 1790-1800.
27. Crecelius AC, Cornett DS, Caprioli RM, Williams B, Dawant BM, Bodenheimer B, (2005). Three-dimensional visualization of protein expression in mouse brain structures using imaging mass spectrometry. J Am Soc Mass Spectrom 16: 1093-1099.
28. Dill AL, Ifa DR, Manicke NE, Ouyang Z, Cooks RG, (2009). Mass spectrometric imaging of lipids using desorption electrospray ionization. J Chromatogr B Analyt Technol Biomed Life Sci 877: 2883-2889.
29. Djidja MC, Francese S, Loadman PM, Sutton CW, Scriven P, Claude E, et al. (2009). Detergent addition to tryptic digests and ion mobility separation prior to MS/MS improves peptide yield and protein identification for in situ proteomic investigation of frozen and formalin-fixed paraffin-embedded adenocarcinoma tissue sections. Proteomics 9: 2750-2763.
30. Douglas DJ, Frank AJ, Mao D, (2005). Linear ion traps in mass spectrometry. Mass Spectrom Rev 24: 1-29.
31. Dreisewerd K, (2003). The desorption process in MALDI. Chem Rev 103: 395-426.
32. Dreisewerd K, (2014). Recent methodological advances in MALDI mass spectrometry. Anal Bioanal Chem 406: 2261-2278.
33. Fehniger TE, Suits F, Vegvari A, Horvatovich P, Foster M, Marko-Varga G, (2014). Queries of MALDI-imaging global datasets identifying ion mass signatures associated with tissue compartments. Proteomics 14: 862-871.
34. Fletcher JS, Lockyer NP, Vickerman JC, (2011). Developments in molecular SIMS depth profiling and 3D imaging of biological systems using polyatomic primary ions. Mass Spectrom Rev 30: 142-174.
35. Franck J, Arafah K, Elayed M, Bonnel D, Vergara D, Jacquet A, et al. (2009). MALDI imaging mass spectrometry: state of the art technology in clinical proteomics. Mol Cell Proteomics 8: 2023-2033.
36. Fuchser J, Cornett S, Becker M, (2014). High resolution molecular imaging of pharmaceuticals at therapeutic levels. Application Note # FTMS-37.
37. Giepmans BN, Adams SR, Ellisman MH, Tsien RY, (2006). The fluorescent toolbox for assessing protein location and function. Science 312: 217-224.
38. Glunde K, Bhujwalla ZM, (2007). Choline kinase alpha in cancer prognosis and treatment. Lancet Oncol 8: 855-857.
39. Glunde K, Ackerstaff E, Natarajan K, Artemov D, Bhujwalla ZM, (2002). Real-time changes in 1H and 31P NMR spectra of malignant human mammary epithelial cells during treatment with the anti-inflammatory agent indomethacin. Magn Reson Med 48: 819-825.
40. Glunde K, Jiang L, Moestue SA, Gribbestad IS, (2011). MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer. NMR Biomed 24: 673-690.
41. Gonnet F, Lemaitre G, Waksman G, Tortajada J, (2003). MALDI/MS peptide mass fingerprinting for proteome analysis: identification of hydrophobic proteins attached to eucaryote keratinocyte cytoplasmic membrane using different matrices in concert. Proteome Sci 1: 2.
42. Goodwin RJ, (2012). Sample preparation for mass spectrometry imaging: small mistakes can lead to big consequences. J Proteomics 75: 4893-4911.
43. Goodwin RJ, Pitt AR, (2010). Mass spectrometry imaging of pharmacological compounds in tissue sections. Bioanalysis 2: 279-293.
44. Goodwin RJ, Dungworth JC, Cobb SR, Pitt AR, (2008). Time-dependent evolution of tissue markers by MALDI-MS imaging. Proteomics 8: 3801-3808.
45. Goodwin RJ, Macintyre L, Watson DG, Scullion SP, Pitt AR, (2010a). A solvent-free matrix application method for matrix-assisted laser desorption/ionization imaging of small molecules. Rapid Commun Mass Spectrom 24: 1682-1686.
46. Goodwin RJ, Scullion P, Macintyre L, Watson DG, Pitt AR, (2010b). Use of a solvent-free dry matrix coating for quantitative matrix-assisted laser desorption ionization imaging of 4-bromophenyl-1,4-diazabicyclo(3.2.2)nonane-4-carboxylate in rat brain and quantitative analysis of the drug from laser microdissected tissue regions. Anal Chem 82: 3868-3873.
47. Goodwin RJ, Pitt AR, Harrison D, Weidt SK, Langridge-Smith PR, Barrett MP, et al. (2011). Matrix-free mass spectrometric imaging using laser desorption ionisation Fourier transform ion cyclotron resonance mass spectrometry. Rapid Commun Mass Spectrom 25: 969-972.
48. Goodwin RJ, Iverson SL, Andren PE, (2012a). The significance of ambient-temperature on pharmaceutical and endogenous compound abundance and distribution in tissues sections when analyzed by matrix-assisted laser desorption/ionization mass spectrometry imaging. Rapid Commun Mass Spectrom 26: 494-498.
49. Goodwin RJ, Nilsson A, Borg D, Langridge-Smith PR, Harrison DJ, Mackay CL, et al. (2012b). Conductive carbon tape used for support and mounting of both whole animal and fragile heat-treated tissue sections for MALDI MS imaging and quantitation. J Proteomics 75: 4912-4920.
50. Grange AH, Donnelly JR, Sovocool GW, Brumley WC, (1996). Determination of elemental compositions from mass peak profiles of the molecular ion (m) and the m + 1 and m + 2 ions. Anal Chem 68: 553-560.
51. Greer T, Sturm R, Li L, (2011). Mass spectrometry imaging for drugs and metabolites. J Proteomics 74: 2617-2631.
52. Groseclose MR, Massion PP, Chaurand P, Caprioli RM, (2008). High-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue microarrays using MALDI imaging mass spectrometry. Proteomics 8: 3715-3724.
53. Gurdak E, Green FM, Rakowska PD, Seah MP, Salter TL, Gilmore IS, (2014). VAMAS interlaboratory study for desorption electrospray ionization mass spectrometry (DESI MS) intensity repeatability and constancy. Anal Chem 86: 9603-9611.
54. Hahn EJ, (1979). Autoradiography of cells double labeled with H-3 and C-14. J Histochem Cytochem 27: 1275.
55. Hamm G, Bonnel D, Legouffe R, Pamelard F, Delbos J-M, Bouzom F, et al. (2012). Quantitative mass spectrometry imaging of propranolol and olanzapine using tissue extinction calculation as normalization factor. J Proteomics 75: 4952-4961.
56. Hankin JA, Murphy RC, (2010). Relationship between MALDI IMS intensity and measured quantity of selected phospholipids in rat brain sections. Anal Chem 82: 8476-8484.
57. Heeren RM, Chughtai K, (2010). Mass spectrometric imaging for biomedical tissue analysis. Chem Rev 110: 3237-3277.
58. Hercules DM, (2002). 9-Aminoacridine as a matrix for negative mode matrix-assisted laser desorption/ionization. Rapid Commun Mass Spectrom 16: 1575-1581.
59. Higashi T, Yamauchi A, Shimada K, (2005). 2-Hydrazino-1-methylpyridine: a highly sensitive derivatization reagent for oxosteroids in liquid chromatography-electrospray ionization-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 825: 214-222.
60. Holle A, Haase A, Kayser M, Hohndorf J, (2006). Optimizing UV laser focus profiles for improved MALDI performance. J Mass Spectrom 41: 705-716.
61. Hsieh Y, Casale R, Fukuda E, Chen J, Knemeyer I, Wingate J, et al. (2006). Matrix-assisted laser desorption/ionization imaging mass spectrometry for direct measurement of clozapine in rat brain tissue. Rapid Commun Mass Spectrom 20: 965-972.
62. Huwiler KG, Mosher DF, Vestling MM, (2003). Optimizing the MALDI-ToF-MS observation of peptides containing disulfide bonds. J Biomol Tech 14: 289-297.
63. Ifa DR, Gumaelius LM, Eberlin LS, Manicke NE, Cooks RG, (2007). Forensic analysis of inks by imaging desorption electrospray ionization (DESI) mass spectrometry. Analyst 132: 461-467.
64. Jaroslav P, Strohalm M, Havlyciek V, Volny M, (2010). Molecular mass spectrometry imaging in biomedical and life science research. Histochem Cell Biol 143: 423-443.
65. Jiao J, Zhang Y, Yang P, Lu H, (2014). Hydrazinonicotinic acid as a novel matrix for highly sensitive and selective MALDI-MS analysis of oligosaccharides. Analyst 140: 156-161.
66. Jones EA, Lockyer NP, Kordys J, Vickerman JC, (2007). Suppression and enhancement of secondary ion formation due to the chemical environment in static-secondary ion mass spectrometry. J Am Soc Mass Spectrom 18: 1559-1567.
67. Kaletaş BK, van der Wiel IM, Stauber J, Güzel C, Kros JM, Luider TM, et al. (2009). Sample preparation issues for tissue imaging by imaging MS. Proteomics 9: 2622-2633.
68. Kallback P, Shariatgorji M, Nilsson A, Andren PE, (2012). Novel mass spectrometry imaging software assisting labeled normalization and quantitation of drugs and neuropeptides directly in tissue sections. J Proteomics 75: 4941-4951.
69. Karas M, (1996). Matrix-assisted laser desorption ionization MS: a progress report. Biochem Soc Trans 24: 897-900.
70. Karas M, Hillenkamp F, (1988). Laser desorption ionization of proteins with molecular masses exceeding 10 000 daltons. Anal Chem 60: 2299-2301.
71. Karas M, Kruger R, (2003). Ion formation in MALDI: the cluster ionization mechanism. Chem Rev 103: 427-440.
72. Kislinger T, Humeny A, Peich CC, Becker CM, Pischetsrieder M, (2005). Analysis of protein glycation products by MALDI-ToF/MS. Proc Natl Acad Sci U S A 1043: 249-259.
73. Knochenmuss R, (2014). MALDI mechanisms: wavelength and matrix dependence of the coupled photophysical and chemical dynamics model. Analyst 139: 147-156.
74. Lalowski M, Magni F, Mainini V, Monogioudi E, Gotsopoulos A, Soliymani R, et al. (2013). Imaging mass spectrometry: a new tool for kidney disease investigations. Nephrol Dial Transplant 28: 1648-1656.
75. Lanao JM, Fraile MA, (2005). Drug tissue distribution: study methods and therapeutic implications. Curr Pharm Des 11: 3829-3845.
76. Langer O, Muller M, (2004). Methods to assess tissue-specific distribution and metabolism of drugs. Curr Drug Metab 5: 463-481.
77. Laskin J, Heath BS, Roach PJ, Cazares L, Semmes OJ, (2012). Tissue imaging using nanospray desorption electrospray ionization mass spectrometry. Anal Chem 84: 141-148.
78. Lemaire R, Menguellet SA, Stauber J, Marchaudon V, Lucot JP, Collinet P, et al. (2007). Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker. J Proteome Res 6: 4127-4134.
79. Lewellen TK, (2008). Recent developments in PET detector technology. Phys Med Biol 53: R287-R317.
80. Liu J, Liu Y, Gao M, Zhang X, (2012). High throughput detection of tetracycline residues in milk using graphene or graphene oxide as MALDI-ToF MS matrix. J Am Soc Mass Spectrom 23: 1424-1427.
81. Liu X, Ide JL, Norton I, Marchionni MA, Ebling MC, Liu LJ, et al. (2013). Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging. Sci Rep 3: 2859.
82. Mange A, Chaurand H, Perrochia H, Roger P, Caprioli RM, Solassol J, (2009). Liquid chromatography-tandem and MALDI imaging mass spectrometry analyses of RCL2/CS100-fixed, paraffin-embedded tissues: proteomics evaluation of an alternate fixative for biomarker discovery. J Proteome Res 8: 5619-5628.
83. Manier ML, Reyzer ML, Goh A, Dartois V, Via LE, Barry CE, et al. (2011). Reagent precoated targets for rapid in-tissue derivatization of the anti-tuberculosis drug isoniazid followed by MALDI imaging mass spectrometry. J Am Soc Mass Spectrom 22: 1409-1419.
84. Marko DC, Saffert RT, Cunningham SA, Hyman J, Walsh J, Arbefeville S, et al. (2012). Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patients. J Clin Microbiol 50: 2034-2039.
85. Meetani MA, Voorhees KJ, (2005). MALDI mass spectrometry analysis of high molecular weight proteins from whole bacterial cells: pretreatment of samples with surfactants. J Am Soc Mass Spectrom 16: 1422-1426.
86. Monro AM, (1990). Interspecies comparisons in toxicology: the utility and futility of plasma concentrations of the test substance. Regul Toxicol Pharmacol 12: 137-160.
87. Monroe EB, Annangudi SP, Hatcher NG, Gutstein HB, Rubakhin SS, Sweedler JV, (2008). SIMS and MALDI MS imaging of the spinal cord. Proteomics 8: 3746-3754.
88. Mouton JW, Theuretzbacher U, Craig WA, Tulkens PM, Derendorf H, Cars O, (2008). Tissue concentrations: do we ever learn? J Antimicrob Chemother 61: 235-237.
89. Nemes P, Vertes A, (2010). Laser ablation electrospray ionization for atmospheric pressure molecular imaging mass spectrometry. Methods Mol Biol 656: 159-171.
90. Nilsson A, Fehniger TE, Gustavsson L, Andersson M, Kenne K, Marko-Varga G, et al. (2010). Fine mapping the spatial distribution and concentration of unlabeled drugs within tissue micro-compartments using imaging mass spectrometry. PLoS ONE 5: e11411.
91. Nilsson A, Forngren B, Bjurström S, Goodwin RJA, Basmaci E, Gustafsson I, et al. (2012). In situ mass spectrometry imaging and ex vivo characterization of renal crystalline deposits induced in multiple preclinical drug toxicology studies. PLoS ONE 7: e47353.
92. Nygren H, Hagenhoff B, Malmberg P, Nilsson M, Richter K, (2007). Bioimaging ToF-SIMS: high resolution 3D imaging of single cells. Microsc Res Tech 70: 969-974.
93. Parson WB, Koeniger SL, Johnson RW, Erickson J, Tian Y, Stedman C, et al. (2012). Analysis of chloroquine and metabolites directly from whole-body animal tissue sections by liquid extraction surface analysis (LESA) and tandem mass spectrometry. J Mass Spectrom 47: 1420-1428.
94. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, Davenport AP, McGrath JC, Peters JA, Southan C, Spedding M, Yu W, Harmar AJ,; NC-IUPHAR. (2014) The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands. Nucl. Acids Res. 42 (Database Issue): D1098-1106.
95. Pierson J, Norris JL, Aerni HR, Svenningsson P, Caprioli RM, Andren PE, (2004). Molecular profiling of experimental Parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry. J Proteome Res 3: 289-295.
96. Prideaux B, Stoeckli M, (2012). Mass spectrometry imaging for drug distribution studies. J Proteomics 75: 4999-5013.
97. Quirke JM, Van Berkel GJ, (2001). Electrospray tandem mass spectrometric study of alkyl 1-methylpyridinium ether derivatives of alcohols. J Mass Spectrom 36: 1294-1300.
98. Reyzer ML, Hsieh Y, Ng K, Korfmacher WA, Caprioli RM, (2003). Direct analysis of drug candidates in tissue by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom 38: 1081-1092.
99. Rohner TC, Staab D, Stoeckli M, (2005). MALDI mass spectrometric imaging of biological tissue sections. Mech Ageing Dev 126: 177-185.
100. Rubakhin SS, Jurchen JC, Monroe EB, Sweedler JV, (2005). Imaging mass spectrometry: fundamentals and applications to drug discovery. Drug Discov Today 10: 823-837.
101. Scannell JW, Blanckley A, Boldon H, Warrington B, (2012). Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov 11: 191-200.
102. Schafer KC, Denes J, Albrecht K, Szaniszlo T, Balog J, Skoumal R, et al. (2009). In vivo, in situ tissue analysis using rapid evaporative ionization mass spectrometry. Angew Chem Int Ed Engl 48: 8240-8242.
103. Schober Y, Guenther S, Spengler B, Rompp A, (2012). Single cell matrix-assisted laser desorption/ionization mass spectrometry imaging. Anal Chem 84: 6293-6297.
104. Schwartz SA, Reyzer ML, Caprioli RM, (2003). Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation. J Mass Spectrom 38: 699-708.
105. Scott AJ, Jones JW, Orschell CM, MacVittie TJ, Kane MA, Ernst RK, (2014). Mass spectrometry imaging enriches biomarker discovery approaches with candidate mapping. Health Phys 106: 120-128.
106. Shariatgorji M, Nilsson A, Goodwin RJA, Svenningsson P, Schintu N, Banka Z, et al. (2012). Deuterated matrix-assisted laser desorption ionization matrix uncovers masked mass spectrometry imaging signals of small molecules. Anal Chem 84: 7152-7157.
107. Shroff R, Svatos A, (2009). 1,8-Bis(dimethylamino)naphthalene: a novel superbasic matrix for matrix-assisted laser desorption/ionization time-of-flight mass spectrometric analysis of fatty acids. Rapid Commun Mass Spectrom 23: 2380-2382.
108. Skold K, Svensson M, Nilsson A, Zhang X, Nydahl K, Caprioli RM, et al. (2006). Decreased striatal levels of PEP-19 following MPTP lesion in the mouse. J Proteome Res 5: 262-269.
109. Smith NF, Raynaud FI, Workman P, (2007). The application of cassette dosing for pharmacokinetic screening in small-molecule cancer drug discovery. Mol Cancer Ther 6: 428-440.
110. Solon EG, (2007). Autoradiography: high-resolution molecular imaging in pharmaceutical discovery and development. Expert Opin Drug Discov 2: 503-514.
111. Solon EG, Schweitzer A, Stoeckli M, Prideaux B, (2010). Autoradiography, MALDI-MS, and SIMS-MS imaging in pharmaceutical discovery and development. AAPS J 12: 11-26.
112. Sooy K, Webster SP, Noble J, Binnie M, Walker BR, Seckl JR, et al. (2010). Partial deficiency or short-term inhibition of 11beta-hydroxysteroid dehydrogenase type 1 improves cognitive function in aging mice. J Neurosci 30: 13867-13872.
113. Stoeckli M, Staab D, Schweitzer A, Gardiner J, Seebach D, (2007). Imaging of a beta-peptide distribution in whole-body mice sections by MALDI mass spectrometry. J Am Soc Mass Spectrom 18: 1921-1924.
114. Streletskii AV, Kozlova A, Esipov DS, Kaiushin AL, Korosteleva MD, Esipov SE, (2005). Determination of oligonucleotide molecular masses by MS-MALDI. Bioorg Khim 31: 151-158.
115. Stumpf WE, (2013). Whole-body and microscopic autoradiography to determine tissue distribution of biopharmaceuticals-target discoveries with receptor micro-autoradiography engendered new concepts and therapies for vitamin D. Adv Drug Deliv Rev 65: 1086-1097.
116. Takats Z, Wiseman JM, Gologan B, Cooks RG, (2004). Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science 306: 471-473.
117. Todd PJ, Schaaff TG, Chaurand P, Caprioli RM, (2001). Organic ion imaging of biological tissue with secondary ion mass spectrometry and matrix-assisted laser desorption/ionization. J Mass Spectrom 36: 355-369.
118. Tolmachev AV, Monroe ME, Jaitly N, Petyuk VA, Adkins JN, Smith RD, (2006). Mass measurement accuracy in analyses of highly complex mixtures based upon multidimensional recalibration. Anal Chem 78: 8374-8385.
119. Troendle FJ, Reddick CD, Yost RA, (1999). Detection of pharmaceutical compounds in tissue by matrix-assisted laser desorption/ionization (MALDI) and laser desorption/chemical ionization (LD/CI) MS/MS with a quadrupole ion trap. J Am Soc Mass Spectrom 10: 1315-1321.
120. Vickerman JC, (2011). Molecular imaging and depth profiling by mass spectrometry-SIMS, MALDI or DESI? Analyst 136: 2199-2217.
121. Weaver EM, Hummon AB, (2013). Imaging mass spectrometry: from tissue sections to cell cultures. Adv Drug Deliv Rev 65: 1039-1055.
122. Wheeler OH, Rosado-Lojo O, (1962). Kinetics of formation and hydrolysis of steroid Girard-T hydrazones. Tetrahedron 18: 477-482.
123. White RE, Manitpisitkul P, (2001). Pharmacokinetic theory of cassette dosing in drug discovery screening. Drug Metab Dispos 29: 957-966.
124. Wiseman JM, Ifa DR, Song Q, Cooks RG, (2006). Tissue imaging at atmospheric pressure using desorption electrospray ionization (DESI) mass spectrometry. Angew Chem Int Ed Engl 45: 7188-7192.
125. Wiseman JM, Ifa DR, Zhu Y, Kissinger CB, Manicke NE, Kissinger PT, et al. (2008). Desorption electrospray ionization mass spectrometry: Imaging drugs and metabolites in tissues. Proc Natl Acad Sci U S A 105: 18120-18125.
126. Wu KJ, Steding A, Becker CH, (1993). Matrix-assisted laser desorption time-of-flight mass spectrometry of oligonucleotides using 3-hydroxypicolinic acid as an ultraviolet-sensitive matrix. Rapid Commun Mass Spectrom 7: 142-146.
127. Yanes O, Woo HK, Northen TR, Oppenheimer SR, Shriver L, Apon J, et al. (2009). Nanostructure initiator mass spectrometry: tissue imaging and direct biofluid analysis. Anal Chem 81: 2969-2975.
128. Zhou P, Altman E, Perry MB, Li J, (2010). Study of matrix additives for sensitive analysis of lipid A by matrix-assisted laser desorption ionization mass spectrometry. Appl Environ Microbiol 76: 3437-3443.
129. Zierhut ML, Yen YF, Chen AP, Bok R, Albers MJ, Zhang V, et al. (2010). Kinetic modeling of hyperpolarized 13C1-pyruvate metabolism in normal rats and TRAMP mice. J Magn Reson 202: 85-92.